Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
Mori T, Ohue M, Takii Y, Hashizume T, Kato T, Kotake K, Sato T, Tango T. Mori T, et al. Among authors: sato t. Oncol Rep. 2013 Feb;29(2):437-44. doi: 10.3892/or.2012.2177. Epub 2012 Dec 10. Oncol Rep. 2013. PMID: 23232805 Clinical Trial.
Current therapeutic strategies for anal squamous cell carcinoma in Japan.
Takashima A, Shimada Y, Hamaguchi T, Ito Y, Masaki T, Yamaguchi S, Kondo Y, Saito N, Kato T, Ohue M, Higashino M, Moriya Y; Colorectal Cancer Study Group of the Japan Clinical Oncology Group. Takashima A, et al. Int J Clin Oncol. 2009 Oct;14(5):416-20. doi: 10.1007/s10147-009-0892-5. Epub 2009 Oct 25. Int J Clin Oncol. 2009. PMID: 19856049
Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205.
Shimada Y, Hamaguchi T, Mizusawa J, Saito N, Kanemitsu Y, Takiguchi N, Ohue M, Kato T, Takii Y, Sato T, Tomita N, Yamaguchi S, Akaike M, Mishima H, Kubo Y, Nakamura K, Fukuda H, Moriya Y. Shimada Y, et al. Among authors: sato t. Eur J Cancer. 2014 Sep;50(13):2231-40. doi: 10.1016/j.ejca.2014.05.025. Epub 2014 Jun 20. Eur J Cancer. 2014. PMID: 24958736 Clinical Trial.
Validation and Modification of the Japanese Classification System for Liver Metastases from Colorectal Cancer: A Multi-institutional Study.
Shinto E, Takahashi K, Yamaguchi T, Hashiguchi Y, Kotake K, Itabashi M, Yasuno M, Kanemitsu Y, Nishimura G, Akagi Y, Sato T, Kato T, Matsumoto H, Hase K, Sugihara K; Study Group for Liver Metastasis projected by the Japanese Society for Cancer of the Colon and Rectum (JSCCR). Shinto E, et al. Among authors: sato t. Ann Surg Oncol. 2015 Nov;22(12):3888-95. doi: 10.1245/s10434-015-4470-y. Epub 2015 Mar 11. Ann Surg Oncol. 2015. PMID: 25758188
Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201).
Sadahiro S, Morita S, Sasaki K, Sakamoto K, Ohge H, Takahashi T, Tsuchiya T, Sato T, Kondo K, Ogata Y, Masuko H, Baba H, Maeda K, Hamada M, Itabashi M, Nishimura G, Takahashi K, Ikeda M, Taguri M, Kodaira S. Sadahiro S, et al. Among authors: sato t. Clin Colorectal Cancer. 2015 Dec;14(4):277-80. doi: 10.1016/j.clcc.2015.05.004. Epub 2015 May 22. Clin Colorectal Cancer. 2015. PMID: 26068602 Free article. Clinical Trial.
Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
Hamaguchi T, Shimada Y, Mizusawa J, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Takiguchi N, Yatsuoka T, Takii Y, Ojima H, Masuko H, Kubo Y, Mishima H, Yamaguchi T, Bando H, Sato T, Kato T, Nakamura K, Fukuda H, Moriya Y. Hamaguchi T, et al. Among authors: sato t. Lancet Gastroenterol Hepatol. 2018 Jan;3(1):47-56. doi: 10.1016/S2468-1253(17)30297-2. Epub 2017 Oct 24. Lancet Gastroenterol Hepatol. 2018. PMID: 29079411 Clinical Trial.
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.
Tomita N, Kunieda K, Maeda A, Hamada C, Yamanaka T, Sato T, Yoshida K, Boku N, Nezu R, Yamaguchi S, Mishima H, Sadahiro S, Muro K, Ishiguro M, Sakamoto J, Saji S, Maehara Y. Tomita N, et al. Among authors: sato t. Br J Cancer. 2019 Apr;120(7):689-696. doi: 10.1038/s41416-019-0410-0. Epub 2019 Mar 5. Br J Cancer. 2019. PMID: 30833647 Free PMC article. Clinical Trial.
Short-term safety of adjuvant chemoradiotherapy after local resection for patients with high-risk submucosal invasive rectal cancer: a single-arm, multicenter phase II trial.
Noguchi M, Shitara K, Kawazoe A, Yamamoto D, Takii Y, Saito Y, Sato T, Horimatsu T, Ishikawa H, Ito Y, Ito M, Ikematsu H. Noguchi M, et al. Among authors: sato t. Jpn J Clin Oncol. 2021 Apr 30;51(5):707-712. doi: 10.1093/jjco/hyaa260. Jpn J Clin Oncol. 2021. PMID: 33558891 Free PMC article. Clinical Trial.
The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006): A Multicenter, Open-label, Randomized, Phase III Trial.
Takii Y, Mizusawa J, Kanemitsu Y, Komori K, Shiozawa M, Ohue M, Ikeda S, Takiguchi N, Kobatake T, Ike H, Sato T, Tomita N, Ota M, Masaki T, Hamaguchi T, Shida D, Katayama H, Shimada Y, Fukuda H; Colorectal Cancer Study Group of Japan Clinical Oncology Group (JCOG). Takii Y, et al. Among authors: sato t. Ann Surg. 2022 May 1;275(5):849-855. doi: 10.1097/SLA.0000000000005241. Epub 2021 Oct 18. Ann Surg. 2022. PMID: 35129519 Clinical Trial.
17,203 results
You have reached the last available page of results. Please see the User Guide for more information.